ZI

Zaheda Iftakhar

Active Director Director DIN 10325181
DIN 10325181 First appointment Sep 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Zaheda Iftakhar

Data last updated:

Zaheda Iftakhar is a Director at Yerise India Pharmaceuticals Private Limited (since 2023). The company operates in Paper.

DIN 10325181
Primary Designation Director
Industry Paper
First Appointment 17 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Sep 20232023Active

Board colleagues of Zaheda Iftakhar

NameDINCompanyDesignation
Sayed Aousaf Ali10325180Yerise India Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yerise India Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Zaheda Iftakhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zaheda Iftakhar

Zaheda Iftakhar currently holds 1 directorship: Yerise India Pharmaceuticals Private Limited (Director, since 17 Sep 2023).

Zaheda Iftakhar was first appointed on 17 Sep 2023 as Director at Yerise India Pharmaceuticals Private Limited.

The current boards of Zaheda Iftakhar's companies include Sayed Aousaf Ali (Yerise India Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available